Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Achar

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
F1000Research|April 4, 2017
Electronic medical records in humanitarian emergencies - the development of an Ebola clinical information and patient management systemKiran Jobanputra, Jane Greig, Ganesh Shankar, et al.
The Lancet. Global Health|November 18, 2022
Global impact of COVID-19 on childhood tuberculosis: an analysis of notification dataLasith Ranasinghe, Jay Achar, Matthias I Gröschel, et al.
BMC Infectious Diseases|September 17, 2020
Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, UzbekistanShona Horter, Beverley Stringer, Nell Gray, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|January 20, 2021
Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort studyAnastasiia Russkikh, Oleksandr Korotych, Yuliia Sereda, et al.
Pathogens (Basel, Switzerland)|April 23, 2022
Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and OpportunitiesPauline Howell, Jay Achar, G Khai Lin Huang, et al.
The European Respiratory Journal|November 9, 2023
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testingJay Achar, James A Seddon, Gwenan M Knight, et al.
Journal of the International AIDS Society|August 4, 2017
Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needsCharles Ssonko, Lucia Gonzalez, Anita Mesic, et al.
Research Square|July 3, 2026
Xpert Ultra on nasopharyngeal swabs detects one-third of pulmonary tuberculosis: a nested case-control study in South African primary careRobinah Nakawunde, Jay Achar, Brian Allwood, et al.
Tropical Medicine & International Health : TM & IH|January 6, 2021
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, UzbekistanHoracio Gil, Hasmik Margaryan, Ismailov Azamat, et al.
BMC Medicine|November 19, 2016
Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, UzbekistanJames M Trauer, Jay Achar, Nargiza Parpieva, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
F1000Research|April 4, 2017
Electronic medical records in humanitarian emergencies - the development of an Ebola clinical information and patient management systemKiran Jobanputra, Jane Greig, Ganesh Shankar, et al.
The Lancet. Global Health|November 18, 2022
Global impact of COVID-19 on childhood tuberculosis: an analysis of notification dataLasith Ranasinghe, Jay Achar, Matthias I Gröschel, et al.
BMC Infectious Diseases|September 17, 2020
Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, UzbekistanShona Horter, Beverley Stringer, Nell Gray, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|January 20, 2021
Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort studyAnastasiia Russkikh, Oleksandr Korotych, Yuliia Sereda, et al.
Pathogens (Basel, Switzerland)|April 23, 2022
Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and OpportunitiesPauline Howell, Jay Achar, G Khai Lin Huang, et al.
The European Respiratory Journal|November 9, 2023
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testingJay Achar, James A Seddon, Gwenan M Knight, et al.
Journal of the International AIDS Society|August 4, 2017
Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needsCharles Ssonko, Lucia Gonzalez, Anita Mesic, et al.
Research Square|July 3, 2026
Xpert Ultra on nasopharyngeal swabs detects one-third of pulmonary tuberculosis: a nested case-control study in South African primary careRobinah Nakawunde, Jay Achar, Brian Allwood, et al.
Tropical Medicine & International Health : TM & IH|January 6, 2021
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, UzbekistanHoracio Gil, Hasmik Margaryan, Ismailov Azamat, et al.
BMC Medicine|November 19, 2016
Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, UzbekistanJames M Trauer, Jay Achar, Nargiza Parpieva, et al.
Pageof 4